EMA partners with content creators to promote safe and responsible use of GLP-1 medicines
21 ottobre 2025
Leggi
Pharmacological therapies for type 2 diabetes: future approaches
Bailey CJ
Diabetologia. Pub. online 31 Oct 2025.
Leggi
Effects of modern glucose monitoring and insulin delivery technologies on patient-reported outcomes and experiences in individuals with type 1 diabetes: a systematic review and meta-analysis
Gao M, Saravanan S, Munyombwe T, et al.
Diabetes Care. Pub. online 30 Oct 2025.
Leggi
An AI-powered lifestyle intervention vs human coaching in the diabetes prevention program: a randomized clinical trial
Mathioudakis N, Lalani B, Abusamaan MS, et al.
JAMA. Pub. online 27 Oct 2025.
Leggi
Comparison of the renal outcomes of novel antidiabetic agents in patients with type 2 diabetes with chronic kidney disease: a systematic review and network meta-analysis of randomized controlled trials
Lin R, Hsu CL, Shih MC, et al.
Diabetes Obes Metab. Pub. online 28 Oct 2025.
Leggi
Sistema nazionale linee guida-ISS: La terapia del diabete mellito di tipo 2. LG multisocietaria
SID – Società Italiana di Diabetologia e Delle Malattie del Metabolismo
AMD – Associazione Medici Diabetologi
28/10/2025
Leggi
Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies
Colombijn JMT, de Leijer JF, Visseren FLJ, et al.
Diabetologia. Pub. online 21 Oct 2025.
Leggi
Safety and glycaemic control during exercise with the MiniMed™ 780G: a narrative review of evidence from lab to real world
Basset-Sagarminaga J, De Block C, Nørgaard K, et al.
Diabetes Obes Metab. Pub. online 19 Oct 2025.
Leggi